ATE500247T1 - Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor - Google Patents
Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitorInfo
- Publication number
- ATE500247T1 ATE500247T1 AT07076124T AT07076124T ATE500247T1 AT E500247 T1 ATE500247 T1 AT E500247T1 AT 07076124 T AT07076124 T AT 07076124T AT 07076124 T AT07076124 T AT 07076124T AT E500247 T1 ATE500247 T1 AT E500247T1
- Authority
- AT
- Austria
- Prior art keywords
- thiochromanes
- chromanes
- thion
- dihydroimidazole
- producing
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 229940122439 Hydroxylase inhibitor Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0223719A GB2393958A (en) | 2002-10-11 | 2002-10-11 | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
| GB0224306A GB2394223B (en) | 2002-10-11 | 2002-10-18 | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE500247T1 true ATE500247T1 (de) | 2011-03-15 |
Family
ID=9945777
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07076124T ATE500247T1 (de) | 2002-10-11 | 2003-10-10 | Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor |
| AT03256420T ATE403652T1 (de) | 2002-10-11 | 2003-10-10 | Imidazolderivate und deren verwendung als peripheral-selektive inhibitoren von dopamin-beta-hydroxylasen |
| AT07076123T ATE550335T1 (de) | 2002-10-11 | 2003-10-10 | 3,4-dihydro-3-amino-2h-1-benzopyran und - benzothiopyran derivate als dopamine-beta- hydroxylase inhibitoren und verfahren zu ihrer herstellung |
| AT07076125T ATE505465T1 (de) | 2002-10-11 | 2003-10-10 | Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung |
| AT07076122T ATE500248T1 (de) | 2002-10-11 | 2003-10-10 | Silyl-geschützte hydroxymethyl-carbamoylalkyl- ketone als intermediate in der herstellung von dopamine-beta-hydroxylase inhibitoren |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03256420T ATE403652T1 (de) | 2002-10-11 | 2003-10-10 | Imidazolderivate und deren verwendung als peripheral-selektive inhibitoren von dopamin-beta-hydroxylasen |
| AT07076123T ATE550335T1 (de) | 2002-10-11 | 2003-10-10 | 3,4-dihydro-3-amino-2h-1-benzopyran und - benzothiopyran derivate als dopamine-beta- hydroxylase inhibitoren und verfahren zu ihrer herstellung |
| AT07076125T ATE505465T1 (de) | 2002-10-11 | 2003-10-10 | Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung |
| AT07076122T ATE500248T1 (de) | 2002-10-11 | 2003-10-10 | Silyl-geschützte hydroxymethyl-carbamoylalkyl- ketone als intermediate in der herstellung von dopamine-beta-hydroxylase inhibitoren |
Country Status (10)
| Country | Link |
|---|---|
| KR (1) | KR101350741B1 (de) |
| CN (1) | CN100393715C (de) |
| AR (2) | AR041589A1 (de) |
| AT (5) | ATE500247T1 (de) |
| CY (2) | CY1108452T1 (de) |
| DE (4) | DE60336276D1 (de) |
| DK (2) | DK1908760T3 (de) |
| ES (5) | ES2364919T3 (de) |
| GB (2) | GB2393958A (de) |
| SI (2) | SI1408038T1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
| JP6161538B2 (ja) * | 2010-12-22 | 2017-07-12 | バイアル−ポルテラ アンド シーエー，エス．エー． | 結晶形及びその製造方法 |
| GB201316410D0 (en) * | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2581556B2 (ja) * | 1986-05-06 | 1997-02-12 | メレルダウファーマスーティカルズ インコーポレーテッド | 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤 |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| WO1995029165A2 (en) * | 1994-04-26 | 1995-11-02 | Syntex (U.S.A.) Inc. | Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors |
-
2002
- 2002-10-11 GB GB0223719A patent/GB2393958A/en not_active Withdrawn
- 2002-10-18 GB GB0224306A patent/GB2394223B/en not_active Expired - Lifetime
-
2003
- 2003-10-10 SI SI200331309T patent/SI1408038T1/sl unknown
- 2003-10-10 DE DE60336276T patent/DE60336276D1/de not_active Expired - Lifetime
- 2003-10-10 ES ES07076125T patent/ES2364919T3/es not_active Expired - Lifetime
- 2003-10-10 DK DK07076125.9T patent/DK1908760T3/da active
- 2003-10-10 SI SI200331986T patent/SI1908760T1/sl unknown
- 2003-10-10 AR ARP030103711A patent/AR041589A1/es active IP Right Grant
- 2003-10-10 ES ES07076124T patent/ES2361939T3/es not_active Expired - Lifetime
- 2003-10-10 AT AT07076124T patent/ATE500247T1/de not_active IP Right Cessation
- 2003-10-10 CN CNB2003801059426A patent/CN100393715C/zh not_active Expired - Fee Related
- 2003-10-10 ES ES03256420T patent/ES2309279T3/es not_active Expired - Lifetime
- 2003-10-10 DE DE60336275T patent/DE60336275D1/de not_active Expired - Lifetime
- 2003-10-10 DE DE60322642T patent/DE60322642D1/de not_active Expired - Lifetime
- 2003-10-10 DK DK03256420T patent/DK1408038T3/da active
- 2003-10-10 ES ES07076122T patent/ES2361938T3/es not_active Expired - Lifetime
- 2003-10-10 KR KR1020127005102A patent/KR101350741B1/ko not_active Expired - Fee Related
- 2003-10-10 AT AT03256420T patent/ATE403652T1/de active
- 2003-10-10 AT AT07076123T patent/ATE550335T1/de active
- 2003-10-10 AT AT07076125T patent/ATE505465T1/de active
- 2003-10-10 AT AT07076122T patent/ATE500248T1/de not_active IP Right Cessation
- 2003-10-10 DE DE60336772T patent/DE60336772D1/de not_active Expired - Lifetime
- 2003-10-10 ES ES07076123T patent/ES2384118T3/es not_active Expired - Lifetime
-
2008
- 2008-10-24 CY CY20081101204T patent/CY1108452T1/el unknown
-
2011
- 2011-07-01 CY CY20111100639T patent/CY1112457T1/el unknown
-
2014
- 2014-03-18 AR ARP140101283A patent/AR095674A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1108452T1 (el) | 2014-04-09 |
| DE60336772D1 (de) | 2011-05-26 |
| GB2393958A (en) | 2004-04-14 |
| ATE550335T1 (de) | 2012-04-15 |
| DE60336276D1 (de) | 2011-04-14 |
| ES2364919T3 (es) | 2011-09-16 |
| ATE500248T1 (de) | 2011-03-15 |
| KR20120038014A (ko) | 2012-04-20 |
| CN1726211A (zh) | 2006-01-25 |
| AR095674A2 (es) | 2015-11-04 |
| GB2394223B (en) | 2007-05-16 |
| ATE505465T1 (de) | 2011-04-15 |
| DE60336275D1 (de) | 2011-04-14 |
| SI1908760T1 (sl) | 2011-05-31 |
| DK1908760T3 (da) | 2011-07-25 |
| ES2361938T3 (es) | 2011-06-24 |
| SI1408038T1 (sl) | 2008-10-31 |
| DE60322642D1 (de) | 2008-09-18 |
| ES2309279T3 (es) | 2008-12-16 |
| GB2394223A (en) | 2004-04-21 |
| DK1408038T3 (da) | 2008-11-24 |
| ATE403652T1 (de) | 2008-08-15 |
| CY1112457T1 (el) | 2015-12-09 |
| ES2361939T3 (es) | 2011-06-24 |
| CN100393715C (zh) | 2008-06-11 |
| HK1116188A1 (en) | 2008-12-19 |
| GB0224306D0 (en) | 2002-11-27 |
| AR041589A1 (es) | 2005-05-26 |
| ES2384118T3 (es) | 2012-06-29 |
| GB0223719D0 (en) | 2002-11-20 |
| KR101350741B1 (ko) | 2014-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE353322T1 (de) | Verfahren zur herstellung von 2- (chinoxalin-5- ylsulfonylamino) -benzamid-verbindungen | |
| DE50107437D1 (de) | Verfahren zur herstellung von polyacrylaten | |
| ATE502058T1 (de) | Verfahren zur herstellung von 1,2-dichlorethan | |
| DE50302301D1 (de) | Verfahren zur herstellung eines formteiles | |
| ATE374463T1 (de) | Verfahren zur herstellung von oxazolidinonen | |
| ATE396180T1 (de) | Verfahren zur herstellung von 2,6-diamino-4,5,6,7-tetrahydrobenzothiazol | |
| ATE414058T1 (de) | Verfahren zur herstellung eines sulfinyl- acetamids | |
| DE60313797D1 (de) | Halbleiter-Lichtemissionsbauelement und Verfahren zu seiner Herstellung | |
| DE60323994D1 (de) | Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan | |
| DE60304119D1 (de) | Verfahren zur Herstellung von dünnwandigen gleichartigen Gitterstrukturen | |
| DE60310023D1 (de) | Verfahren zur schmelzfreien Herstellung eines Schweissstabes | |
| ATE466016T1 (de) | Verfahren for zur herstellung eines 14- hydroxynormorphinon-derivats | |
| ATE376997T1 (de) | Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten | |
| ATE456569T1 (de) | Verfahren zur herstellung von 6-alkyliden- penemderivaten | |
| DE10242955B4 (de) | Kunststoffaß und Verfahren zur Herstellung des Fasses | |
| ATE553103T1 (de) | Verfahren zur herstellung von (s)-pantoprazol | |
| DE60336726D1 (de) | Hafniumsilicid-target und verfahren zu seiner herstellung | |
| ATE399764T1 (de) | Verfahren zur herstellung von bisepoxiden und dithiolen | |
| ATE548348T1 (de) | Verfahren zur herstellung des r,r (oder s,s) konfigurierten glycopyrronium-stereoisomers | |
| ATE430140T1 (de) | Verfahren zur herstellung von ä1,4,5ü- oxadiazepinderivaten | |
| ATE328010T1 (de) | Verfahren zur herstellung von polyisobuten | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| ATE349442T1 (de) | Verbessertes verfahren zur herstellung von alpha- polymorphem eletriptan hydrobromid | |
| ATE402138T1 (de) | Verfahren zur herstellung von 2- aminoindanderivaten | |
| ATE500247T1 (de) | Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |